KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Consolidated Net Income: 2018-2025

Historic Consolidated Net Income for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$27.1 million.

  • Twist Bioscience's Consolidated Net Income rose 21.79% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.7 million, marking a year-over-year increase of 62.79%. This contributed to the annual value of -$77.7 million for FY2025, which is 62.80% up from last year.
  • Twist Bioscience's Consolidated Net Income amounted to -$27.1 million in Q3 2025, which was down 232.97% from $20.4 million recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Consolidated Net Income peaked at $20.4 million during Q2 2025, and registered a low of -$85.6 million during Q2 2024.
  • For the 3-year period, Twist Bioscience's Consolidated Net Income averaged around -$40.8 million, with its median value being -$43.0 million (2023).
  • Per our database at Business Quant, Twist Bioscience's Consolidated Net Income plummeted by 69.47% in 2021 and then soared by 123.82% in 2025.
  • Twist Bioscience's Consolidated Net Income (Quarterly) stood at -$45.6 million in 2021, then climbed by 8.21% to -$41.8 million in 2022, then declined by 2.83% to -$43.0 million in 2023, then climbed by 26.53% to -$31.6 million in 2024, then climbed by 21.79% to -$27.1 million in 2025.
  • Its last three reported values are -$27.1 million in Q3 2025, $20.4 million for Q2 2025, and -$39.4 million during Q1 2025.